The 48 references in paper A. Budnevskiy V., L. Tsvetikova N., E. Ovsyannikov S., O. Goncharenko V., А. Будневский В., Л. Цветикова Н., Е. Овсянников С., О. Гончаренко В. (2016) “Мелатонин: роль в развитии хронической обструктивной болезни легких // A role of melatonin for occurrence of chronic obstructive pulmonary disease” / spz:neicon:pulmonology:y:2016:i:3:p:372-378

1
Атякшин Д.А., Цветикова Л.Н., Лобеева Н.В. и др. По" казатели иммунного статуса при хронической обструк" тивной болезни легких. Успехи современного естество# знания. 2015; 9 (2): 195–197.
(check this in PDF content)
2
Ito K., Mercado N. STOP accelerating lung aging for the treatment of COPD.Exp. Gerontol.2014; 59: 21–27.
(check this in PDF content)
3
Ito K., Colley T., Mercado N. Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging dis" ease. Int. J. Chron. Obstruct. Pulm. Dis. 2012; 7: 641–652.
(check this in PDF content)
4
Владимиров Ю.А. Шерстнев М.П., Азимбаев Т.К. Оценка антиокислительной и антирадикальной актив" ности веществ и биологических объектов. Биофизика. 1992; 37: 1041–1047.
(check this in PDF content)
5
Абрамова Ж.И., Оксенгендлер Г.И. Человек и противо" окислительные вещества. М.: Наука; 1985.
(check this in PDF content)
6
Кветная Т.В., Князькин И.В., Кветной И.М. Мелато" нин – нейроиммуноэндокринный маркер возрастной патологии. СПб: ДЕАН; 2005.
(check this in PDF content)
7
Князькин И.В. Экстрапинеальный мелатонин в про" цессе старения. СПб: Институт биорегуляции и герон" тологии СЗО РАМН. 2008.
(check this in PDF content)
8
Анисимов В.Н. Физиологические функции эпифиза (геронтологический аспект).Российский физиологичес# кий журнал им. И.М.Сеченова. 1998; 83: 1–10.
(check this in PDF content)
9
Наумов Е.В., Попова Н.К. Серотонин и мелатонин в регуляции эндокринной системы. Новосибирск: На" ука; 1975.
(check this in PDF content)
10
Дятлов Р.В. Сравнение антиоксидантных свойств ме" латонина, эпиталамина и глютатиона методом люми" нолзависимой хемилюминесценции in vitro.Доклады РАН. 1997; 356: 129–131.
(check this in PDF content)
11
Газиев А.И., Ушакова Т.Е., Подлуцкий А.Я. Диетичес" кие антиоксиданты увеличивают продолжительность жизни мышей, снижают частоту мутаций и увеличива" ют экспрессию защитных генов.Успехи геронтологии. 1997; 1: 80–84.
(check this in PDF content)
12
Осипов А.Н., Азизова Ю.А., Владимиров Ю.А. Актив" ные формы кислорода и их роль в организме. Успехи биологической химии.1990; 31 (2): 180–208.
(check this in PDF content)
13
Hong Y.G., Riegler J.L. Is melatonin associated with the development of autoimmune hepatitis? J. Clin. Gastro# enterol. 1997; 25 (1): 376–378.
(check this in PDF content)
14
Martin M., Macias M., Leon J. et al. Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int. J. Biochem. Cell Biol. 2002; 34 (4): 348–357.
(check this in PDF content)
15
Kücükakin B., Gögenur I., Reiter R.J. et al. Oxidative stress in relation to surgery: is there a role for the antioxidant melatonin. J. Surg. Res. 2009; 152 (2): 338–347.
(check this in PDF content)
16
Yilmaz S., Yilmaz E. Effects of melatonin and vitamin E on oxidative"antioxidative status in rats exposed to irradiation. Toxicology. 2006; 222 (1–2): 1–7.
(check this in PDF content)
17
Ulusu N.N., Sahilli M., Avci A. et al. Pentose phosphate pathway, glutathione"dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E. Neurochem. Res.2003; 28 (6): 815–823.
(check this in PDF content)
18
Montilla P., Cruz A., Padillo F.J. et al. Melatonin versus vitamin E as protective treatment against oxidative stress after extra"hepatic bile duct ligation in rats. J. Pineal. Res. 2001; 31 (2): 138–144.
(check this in PDF content)
19
Baydas G., Ercel E., Canatan H. et al. Effect of melatonin on oxidative status of rat brain, liver and kidney tissues under constant light exposure. Cell Biochem. Funct.2001; 19 (1): 37–41.
(check this in PDF content)
20
Subramanian P., Dakshayani K.B., Pandi"Perumal S.R. et al. 24"hour rhythms in oxidative stress during hepatocarcino" genesis in rats: effect of melatonin or alpha"ketoglutarate. Redox. Rep. 2008; 13 (2): 78–86.
(check this in PDF content)
21
Sewerynek E., Melchiorri D., Reiter R.J. et al. Lipopolysaccharide"induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur. J. Pharmacol.1995; 293 (4): 327–334.
(check this in PDF content)
22
Öztürk G., Coşkun S., ErbaşD., Hasanog ̆lu E. The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels.Japan. J. Physiology. 2000; 50: 149–153.
(check this in PDF content)
23
Hardeland R., Coto"Montes A., Poeggeler B. Circadian rhythms, oxidative stress, and antioxidative defense mecha" nisms.Chronobiol. Int. 2003; 20 (6): 921–962.
(check this in PDF content)
24
Vural H., Sabuncu T., Arslan S.O. et al. Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats.J. Pineal. Res. 2001; 31 (3): 193–198.
(check this in PDF content)
25
Esrefoglu M., Gül M., Emre M.H. et al. Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats. World J. Gastro# enterol. 2005; 11 (13): 1951–1956.
(check this in PDF content)
26
Cuzzocrea S., Zingarelli B., Gilad E. et al. Protective of melatonin in carrageenan"induced models of local inflam" mation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J. Pineal. Res.1997; 23 (2): 106–116.
(check this in PDF content)
27
Maharaj D.S., Limson J.L., Daya S. 6"Hydroxymelatonin converts Fe (III) to Fe (II) and reduces iron"induced lipid peroxidation.Life Sci. 2003; 72 (12): 1367–1375. Будневский А.В. и др.Мелатонин: роль в развитии хронической обструктивной болезни легких
(check this in PDF content)
28
Reiter R.J., Tan D.X., Gitto E. et al. Pharmacological util" ity of melatonin in reducing oxidative cellular and molecu" lar damage.Pol. J. Pharmacol. 2004; 56 (2): 159–170.
(check this in PDF content)
29
Cruz A. Effect of melatonin on myocardial oxidative stress induced by experimental obstructive jaundice. Rev. Esp. Enferm. Dig.2009; 101 (7): 460–463.
(check this in PDF content)
30
Ohta Y., Kongo M., Kishikawa T. Melatonin exerts a thera" peutic effect on cholestatic liver injury in rats with bile duct ligation.J. Pineal. Res.2003; 34 (2): 119–126.
(check this in PDF content)
31
Cruz A., Tasset I., Ramírez L.M. et al. Melatonin protects against renal oxidative stress after obstructive jaundice in rats. Eur. J. Pharmacol.2001; 425 (2): 135–139.
(check this in PDF content)
32
Обухова Л.К., Эмануэль Н.М. Роль свободнорадикаль" ных реакций окисления в молекулярных механизмах старения живых организмов. Успехи химии.1983; 52: 353–372.
(check this in PDF content)
33
Пескин A.В. Взаимодействие активного кислорода с ДНК. Биохимия. 1997; 62: 1571–1578.
(check this in PDF content)
34
Kojima T. Effects of melatonin on proliferation, oxidative stress and Cx32 gap junction protein expression in primary cultures of adult rat hepatocytes.Cell. Struct. Funct.1997; 22 (3): 347–356.
(check this in PDF content)
35
El"Sokkary G.H. Inhibition of 2"nitropropane"induced cel" lular proliferation, DNA synthesis and histopathological changes by melatonin.Neuroendocrinol. Lett.2002; 23 (4): 335–340.
(check this in PDF content)
36
Sewerynek E., Reiter R.J., Melchiorri D. et al. Oxidative damage in the liver induced by ischemia"reperfusion: pro" tection by melatonin Hepatogastroenterology. 1996; 43 (10): 898–905.
(check this in PDF content)
37
Munoz"Casares F.C., Padillo F.J., Briceño J. et al. Melatonin reduces apoptosis and necrosis induced by ischemia / reperfusion injury of the pancreas.J. Pineal. Res. 2006; 40 (3): 195–203.
(check this in PDF content)
38
Ozen O.A., Kus M.A., Kus I. et al. Protective effects of melatonin against formaldehyde"induced oxidative damage and apoptosis in rat testes: an immunohistochemical and biochemical study. Syst. Biol. Reprod. Med. 2008; 54 (4–5): 169–176.
(check this in PDF content)
39
Gumral N., Naziroglu M., Ongel K. et al. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods.Cell. Biochem. Funct.2009; 27 (5): 276–283.
(check this in PDF content)
40
Matos Cavalcante A.G., de Bruin P.F., de Bruin V.M. et al. Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, dou" ble"blind, placebo"controlled study.J. Pineal. Res.2012; 53 (3): 238–244.
(check this in PDF content)
41
Kim G.D., Lee S.E., Kim T.H. et al. Melatonin suppresses acrolein"induced IL"8 production in human pulmonary fibroblasts. J. Pineal. Res.2012; 52 (3): 356–364.
(check this in PDF content)
42
Shin I.S., Shin N.R., Park J.W. et al. Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke"induced chronic obstructive pulmonary diseases via the suppression of Erk"Sp1 signaling.J. Pineal. Res. 2015; 58 (1): 50–60.
(check this in PDF content)
43
Shin I.S., Park J.W., Shin N.R. et al. Melatonin inhibits MUC5AC production via suppression of MAPK signaling in human airway epithelial cells.J. Pineal. Res. 2014; 56 (4): 398–407.
(check this in PDF content)
44
Roth T. Hypnotic use for insomnia management in chronic obstructive pulmonary disease. Sleep Med.2009; 10 (1): 19–25.
(check this in PDF content)
45
Kryger M., Roth T., Wang"Weigand S., Zhang J. The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease. Sleep Breath. 2009; 13 (1): 79–84.
(check this in PDF content)
46
Kryger M., Wang"Weigand S., Zhang J., Roth T. Effect of ramelteon, a selective MT(1)/MT (2)"receptor agonist, on respiration during sleep in mild to moderate COPD. Sleep Breath. 2008; 12 (3): 243–250.
(check this in PDF content)
47
Nunes D.M., Mota R.M.S., Machado M.O. et al. Effect of melatonin administration on subjective sleep quality in chronic obstructive pulmonary disease. Braz. J. Med. Biol. Res.2008; 41 (10): 926–931.
(check this in PDF content)
48
Halvani A., Mohsenpour F., Nasiriani K. Evaluation of exogenous melatonin administration in improvement of sleep quality in patients with chronic obstructive pulmonary disease. Tanaffos. 2013; 12 (2): 9–15. Поступила 30.11.15
(check this in PDF content)